Edition:
United States

Cosmo Pharmaceuticals' Aemcolo NDA Accepted by FDA


Monday, 21 May 2018 10:59am EDT 

May 21 (Reuters) - Cosmo Pharmaceuticals NV ::FDA ACCEPTS NEW DRUG APPLICATION FOR AEMCOLO (RIFAMYCIN SV MMX®) AND SETS PDUFA DATE FOR NOVEMBER 16, 2018.COSMO PHARMACEUTICALS NV - UPON FDA APPROVAL OF AEMCOLO, ARIES PHARMACEUTICALS TO LEAD U.S. COMMERCIAL EFFORTS. 

Company Quote

112.3
-0.7 -0.62%
4:00am EDT